Original article
Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial
M. Lichtblaua,1, S. Saxera,1, J. Müllera, P. Appenzellera, C. Berliera, S.R. Schneidera, L. Mayera, M. Furiana, E.I. Schwarza, E.R. Swensonb, K.E. Blocha,c, S. Ulricha,c,
Corresponding author
silvia.ulrich@usz.ch
Corresponding author at: Department of Pulmonology, University Hospital Zurich, Raemistrasse 100, 8091, Zürich, Switzerland.
Corresponding author at: Department of Pulmonology, University Hospital Zurich, Raemistrasse 100, 8091, Zürich, Switzerland.
a Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland
b Division of Pulmonary, Critical Care and Sleep Medicine, VA Puget Sound Health Care System, University of Washington, Seattle, Washington, USA
c Center for Human Integrative Physiology, and Zurich Center for Interdisciplinary Sleep Research, University of Zurich, Switzerland
Read
1348
Timeswas read the article
453
Total PDF
895
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 April | 62 | 34 | 96 |
| 2024 March | 86 | 29 | 115 |
| 2024 February | 48 | 43 | 91 |
| 2024 January | 62 | 18 | 80 |
| 2023 December | 37 | 23 | 60 |
| 2023 November | 61 | 47 | 108 |
| 2023 October | 49 | 38 | 87 |
| 2023 September | 54 | 23 | 77 |
| 2023 August | 56 | 14 | 70 |
| 2023 July | 47 | 23 | 70 |
| 2023 June | 55 | 24 | 79 |
| 2023 May | 81 | 37 | 118 |
| 2023 April | 58 | 20 | 78 |
| 2023 March | 70 | 16 | 86 |
| 2023 February | 31 | 31 | 62 |
| 2023 January | 38 | 33 | 71 |
Show all
